| All respondents | No alcohol consumption | Non-hazardous drinking | Hazardous drinking |  |
---|---|---|---|---|---|
 | n = 1,238 | n = 140 | n = 834 | n = 264 | pb |
Number of tender joints (of 28) | 3 (1–8) | 4 (1–11) | 3 (1–8) | 3 (1–7) | 0.02 |
Men | 2 (0–6) | 2 (0–5) | 2 (0–6) | 2 (0–5.25) | 0.94 |
Women | 4 (1–10) | 5 (2–12) | 4 (1–9) | 3 (1–7.25) | 0.03 |
Number of swollen joints (of 28) | 1 (0–5) | 2 (0–6) | 2 (0–5) | 1 (0–4) | 0.11 |
Men | 0 (0–3) | 0 (0–1) | 0 (0–4) | 1 (0–3) | 0.31 |
Women | 2 (0–6) | 2 (0–6) | 2 (0–6) | 1 (0–4) | 0.05 |
VAS global, mm | 30 (10–50) | 40 (20–50) | 30 (10–50) | 20 (10–40) | 0.0001 |
Men | 20 (10–50) | 20 (10–45) | 20 (10–40) | 20 (10–40) | 0.69 |
Women | 30 (10–50) | 40 (20–60) | 30 (20–50) | 20 (10–40) | 0.0001 |
VAS pain, mm | 30 (10–50) | 40 (20–60) | 30 (10–50) | 30 (10–50) | 0.001 |
Men | 30 (10–50) | 30 (20–40) | 20 (10–40) | 20 (0–40) | 0.18 |
Women | 40 (20–60) | 40 (20–60) | 30 (20–50) | 30 (10–60) | 0.03 |
EuroQol | 0.76 (0.69–0.80) | 0.73 (0.62–0.80) | 0.76 (0.69–0.80) | 0.80 (0.73–0.80) | 0.0001 |
Men | 0.80 (0.73–0.85) | 0.73 (0.67–0.80) | 0.80 (0.73–0.85) | 0.80 (0.73–1.0) | 0.07 |
Women | 0.73 (0.66–0.80) | 0.73 (0.59–0.80) | 0.73 (0.69–0.80) | 0.80 (0.73–0.80) | 0.005 |
HAQ | 0.38 (0–0.90) | 0.75 (0.25–1.38) | 0.5 (0–0.88) | 0.25 (0–0.75) | 0.0001 |
Men | 0.25 (0–0.75) | 0.13 (0–0.44) | 0.25 (0–0.63) | 0.13 (0–0.75) | 0.80 |
Women | 0.63 (0.13–1.239 | 0.88 (0.34–1.38) | 0.50 (0.13–1.0) | 0.38 (0–0.75) | 0.0001 |
Number of current DMARDs and biologics, mean (SD) | 1.1 (0.8) | 0.9 (0.9) | 1.1 (0.7) | 1.2 (0.8) | 0.03 |
Men | 1.0 (0.7) | 1.1 (0.7) | 1.0 (0.7) | 1.2 (0.7) | 0.30 |
Women | 1.1 (0.8) | 0.9 (0.9) | 1.1 (0.7) | 1.1 (0.9) | 0.02 |
Number of previous DMARDs and biologics, mean (SD) | 1.7 (1.4) | 1.5 (1.2) | 1.8 (1.5) | 1.7 (1.3) | 0.18 |
Men | 1.0 (0.7) | 1.3 (0.5) | 1.5 (1.3) | 1.6 (1.1) | 0.24 |
Women | 1.8 (1.5) | 1.5 (1.2) | 1.9 (1.6) | 1.8 (1.3) | 0.03 |